Drug
Vapendavir clinical trials
Also written BTA798.
- studies test it
- 10
- open now
- 1
- in phase 3
- 0
- first study started
- 2010
Keep track of what changes. Save the vapendavir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
9 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Altesa Biosciences, Inc. (4) · Biota Pharmaceuticals, Inc. (2) · Biota Scientific Management Pty Ltd (2) · Aviragen Therapeutics (1) · Vaxart (1)
Often tested with
Tested in the same studies.
VPV 500 (1)
Studies
Open first, then newest update. How each study uses vapendavir is read from its arms, and is right about nine times in ten.
Testing it · 10
- Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDRecruitingPhase 2Altesa Biosciences, Inc.NCT07610395Written as VPV 1000 mg
- RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionCompletedPhase 2Altesa Biosciences, Inc.NCT06149494Written as Vapendavir
- A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]VapendavirCompletedPhase 1/2Altesa Biosciences, Inc.NCT06834295Written as Vapendavir
- Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPDCompletedPhase 1Altesa Biosciences, Inc.NCT05962645Written as Vapendavir
- A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy VolunteersCompletedPhase 1Aviragen TherapeuticsNCT02877264Written as vapendavir 132 mg capsule
- A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionCompletedPhase 2Biota Pharmaceuticals, Inc.NCT02367313Written as Vapendavir
- A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionCompletedPhase 2Biota Scientific Management Pty LtdNCT01175226Written as BTA798
- A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy VolunteersCompletedPhase 1Biota Pharmaceuticals, Inc.NCT02101866Written as Vapendavir 300 mg tablet
- A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female VolunteersCompletedPhase 1Biota Scientific Management Pty LtdNCT02204501Written as Vapendavir 264 mg BID
- A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus InfectionWithdrawnPhase 2VaxartNCT03024177Written as Vapendavir
Codes
What other systems call vapendavir · ClinicalTrials.gg INT017662
- UNII (FDA) Q8LVL5Z68HVAPENDAVIRConfirmed FDA, Wikidata
- Wikidata Q27287117vapendavirConfirmed FDA, Wikidata
- NCI Thesaurus C152831VapendavirOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Q8LVL5Z68H | VAPENDAVIR | Confirmed FDA, Wikidata |
| Wikidata | Q27287117 | vapendavir | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152831 | Vapendavir | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.